Profiel
Dayan Colin is currently the Chair of Clinical Diabetes and Metabolism and Head at the University of Cardiff, as well as a Partner and Advisor at JDRF T1D Fund.
Previously, he was the Director at the Institute of Molecular Immunology.
Mr. Colin received a doctorate degree from University College Oxford.
Actieve functies van Dayan Colin
| Bedrijven | Functie | Begin |
|---|---|---|
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Consultant / Adviseur | - |
| University of Cardiff | Voorzitter | - |
Eerdere bekende functies van Dayan Colin
| Bedrijven | Functie | Einde |
|---|---|---|
| Institute of Molecular Immunology | Directeur/Bestuurslid | - |
Opleiding van Dayan Colin
| University College Oxford | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Institute of Molecular Immunology | |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
